Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GILEAD SCIENCES, INC.GILD · Entity 405 | Director | April 30, 2026 | May 04, 2026 |
| Nielsen Holdings plcNLSN · Entity 16431 | Director | March 18, 2021 | March 22, 2021 |
| QUALCOMM INC/DEQCOM · Entity 2852 | Director | April 05, 2021 | April 06, 2021 |
| WHIRLPOOL CORP /DE/WHR · Entity 4355 | Director | April 15, 2025 | April 16, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GILEAD SCIENCES, INC.
Report date April 30, 2026 · Filed May 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,239 |
Reported balance
After 2026-04-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-30 · Grant · Acquired 1,146 · Balance 15,239 F1: Represents 1,146 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of April 30, 2026. |
| Common StockSEC Table I · non-derivative | Direct | 15,015 |
Reported balance
After 2026-04-30 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-04-30 · Tax withholding · Disposed 224 · Balance 15,015 |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $130.84 · Expires 2036-04-30 | Direct | 4,884 |
Reported balance
After 2026-04-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-30 · Grant · Acquired 4,884 · Balance 4,884 F2: 100% of the shares subject to the stock option vested immediately upon the grant date of April 30, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 1,146 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of April 30, 2026.
F2: 100% of the shares subject to the stock option vested immediately upon the grant date of April 30, 2026.
Nielsen Holdings plc
Report date March 18, 2021 · Filed March 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,940.061 |
Reported balance
After 2021-03-18 transaction · row 1
1 source rowRow 1 · 2021-03-18 · Grant · Acquired 84.982 · Balance 36,940.061 F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units.
QUALCOMM INC/DE
Report date April 05, 2021 · Filed April 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Indirectby Joint Account | 16,178 |
Last balance in matching sequence
After 2021-04-05 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2021-04-05 · Exercise / conversion · Acquired 4,134 · Balance 16,798 F1: Securities held by Harish and Radha Manwani. Row 2 · 2021-04-05 · Tax withholding · Disposed 620 · Balance 16,178 F1: Securities held by Harish and Radha Manwani. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 9,578.6065 |
Reported balance
After 2021-04-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-04-05 · Exercise / conversion · Disposed 4,134.6854 · Balance 9,578.6065 F2: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F3: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. |
Filing footnotes · ownership attribution and instrument terms
F1: Securities held by Harish and Radha Manwani.
F2: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock.
F3: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control.
WHIRLPOOL CORP /DE/
Report date April 15, 2025 · Filed April 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,622 |
Ending reported balance
After 2025-04-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-04-15 · Grant · Acquired 2,014 · Balance 13,015 F1: Annual stock award granted under the Omnibus Stock and Incentive Plan. Row 2 · 2025-04-15 · Tax withholding · Disposed 393 · Balance 12,622 |
Filing footnotes · ownership attribution and instrument terms
F1: Annual stock award granted under the Omnibus Stock and Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 30, 2026 Filed May 4, 2026 20:20 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 4,884 | $0.00 Strike: $130.84 | $0.00 |
DisclosureSEC source: 0001527726-26-000002 · wk-form4_1777926054.xml · derivative · entry 3 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,884 Underlying: Common Stock · 4,884 shares Expires 2036-04-30 F2 · derivative.exercise_date: 100% of the shares subject to the stock option vested immediately upon the grant date of April 30, 2026. Read SEC document |
| April 30, 2026 Filed May 4, 2026 20:20 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Tax withholdingCommon Stock | 224 | $130.84 | $29,308.16 |
DisclosureSEC source: 0001527726-26-000002 · wk-form4_1777926054.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,015 Read SEC document |
| April 30, 2026 Filed May 4, 2026 20:20 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantCommon Stock | 1,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001527726-26-000002 · wk-form4_1777926054.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,239 F1 · security: Represents 1,146 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of April 30, 2026. Read SEC document |
| May 07, 2025 Filed May 9, 2025 00:18 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 6,809 | $0.00 Strike: $98.90 | $0.00 |
DisclosureSEC source: 0001127602-25-013773 · form4.xml · derivative · entry 3 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,809 Underlying: Common Stock · 6,809 shares Expires 2035-05-07 F2 · derivative.exercise_date: 100% of the shares subject to the stock option vested immediately upon the grant date of May 7, 2025. Read SEC document |
| May 07, 2025 Filed May 9, 2025 00:18 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Tax withholdingCommon Stock | 296 | $98.90 | $29,274.40 |
DisclosureSEC source: 0001127602-25-013773 · form4.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,093 Read SEC document |
| May 07, 2025 Filed May 9, 2025 00:18 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantCommon Stock | 1,516 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-013773 · form4.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,389 F1 · security: Represents 1,516 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 7, 2025. Read SEC document |
| April 15, 2025 Filed Apr 16, 2025 21:48 UTC | WHIRLPOOL CORP /DE/ WHR · Entity 4355 | Tax withholdingCommon Stock | 393 | $79.43 | $31,215.99 |
DisclosureSEC source: 0000106640-25-000064 · wk-form4_1744840085.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,622 Read SEC document |
| April 15, 2025 Filed Apr 16, 2025 21:48 UTC | WHIRLPOOL CORP /DE/ WHR · Entity 4355 | GrantCommon Stock | 2,014 | $0.00 | $0.00 |
DisclosureSEC source: 0000106640-25-000064 · wk-form4_1744840085.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,015 F1 · price: Annual stock award granted under the Omnibus Stock and Incentive Plan. Read SEC document |
| May 08, 2024 Filed May 9, 2024 21:16 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 12,648 | $0.00 Strike: $64.92 | $0.00 |
DisclosureSEC source: 0001127602-24-014812 · form4.xml · derivative · entry 3 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,648 Underlying: Common Stock · 12,648 shares Expires 2034-05-08 F2 · derivative.exercise_date: 100% of the shares subject to the stock option vested immediately upon the grant date of May 8, 2024. Read SEC document |
| May 08, 2024 Filed May 9, 2024 21:16 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Tax withholdingCommon Stock | 451 | $64.92 | $29,278.92 |
DisclosureSEC source: 0001127602-24-014812 · form4.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,873 Read SEC document |
| May 08, 2024 Filed May 9, 2024 21:16 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantCommon Stock | 2,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-014812 · form4.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,324 F1 · security: Represents 2,310 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 8, 2024. Read SEC document |
| April 16, 2024 Filed Apr 17, 2024 20:54 UTC | WHIRLPOOL CORP /DE/ WHR · Entity 4355 | Tax withholdingCommon Stock | 278 | $105.55 | $29,342.90 |
DisclosureSEC source: 0000106640-24-000076 · wk-form4_1713387272.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,001 F2 · balance_after: Certain shares previously reported as indirectly held are now reported as directly held, consistent with the instructions to Form 4. Read SEC document |
| April 16, 2024 Filed Apr 17, 2024 20:54 UTC | WHIRLPOOL CORP /DE/ WHR · Entity 4355 | GrantCommon Stock | 1,421 | $0.00 | $0.00 |
DisclosureSEC source: 0000106640-24-000076 · wk-form4_1713387272.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,279 F1 · price: Annual stock award granted under the Omnibus Stock and Incentive Plan. Read SEC document |
| May 03, 2023 Filed May 4, 2023 21:51 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 10,173 | $79.45 Strike: $79.45 | $808,244.85 |
DisclosureSEC source: 0001127602-23-014548 · form4.xml · derivative · entry 3 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,173 Underlying: Common Stock · 10,173 shares Expires 2033-05-03 F2 · derivative.exercise_date: 100% of the shares subject to the stock option vested immediately upon the grant date of May 3, 2023. Read SEC document |
| May 03, 2023 Filed May 4, 2023 21:51 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Tax withholdingCommon Stock | 368 | $79.45 | $29,237.60 |
DisclosureSEC source: 0001127602-23-014548 · form4.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,014 Read SEC document |
| May 03, 2023 Filed May 4, 2023 21:51 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantCommon Stock | 1,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-014548 · form4.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,382 F1 · security: Represents 1,887 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 3, 2023. Read SEC document |
| April 18, 2023 Filed Apr 20, 2023 21:27 UTC | WHIRLPOOL CORP /DE/ WHR · Entity 4355 | Tax withholdingCommon Stock | 210 | $0.00 | $0.00 |
DisclosureSEC source: 0000106640-23-000074 · wf-form4_168202604570281.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 864 Read SEC document |
| April 18, 2023 Filed Apr 20, 2023 21:27 UTC | WHIRLPOOL CORP /DE/ WHR · Entity 4355 | GrantCommon Stock | 1,074 | $0.00 | $0.00 |
DisclosureSEC source: 0000106640-23-000074 · wf-form4_168202604570281.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,074 F1 · price: Annual stock award granted under the Omnibus Stock and Incentive Plan. Read SEC document |
| July 26, 2022 Filed Feb 14, 2023 22:53 UTC | WHIRLPOOL CORP /DE/ WHR · Entity 4355 | GiftCommon | 8,994 | $0.00 | $0.00 |
DisclosureSEC source: 0000106640-23-000019 · wf-form5_167641518749174.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Limited Partnership of reporting person Disclosed balance after: 8,994 Read SEC document |
| July 26, 2022 Filed Feb 14, 2023 22:53 UTC | WHIRLPOOL CORP /DE/ WHR · Entity 4355 | GiftCommon Stock | 8,994 | $0.00 | $0.00 |
DisclosureSEC source: 0000106640-23-000019 · wf-form5_167641518749174.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 05, 2022 Filed May 6, 2022 22:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 15,851 | $0.00 Strike: $61.35 | $0.00 |
DisclosureSEC source: 0001127602-22-013718 · form4.xml · derivative · entry 3 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,851 Underlying: Common Stock · 15,851 shares Expires 2032-05-05 F2 · derivative.exercise_date: 100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022. Read SEC document |
| May 05, 2022 Filed May 6, 2022 22:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Tax withholdingCommon Stock | 477 | $61.35 | $29,263.95 |
DisclosureSEC source: 0001127602-22-013718 · form4.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,495 Read SEC document |
| May 05, 2022 Filed May 6, 2022 22:39 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantCommon Stock | 2,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-013718 · form4.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,972 F1 · security: Represents 2,444 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 5, 2022. Read SEC document |
| May 03, 2022 Filed May 4, 2022 00:11 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 2,223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-013124 · form4.xml · derivative · entry 3 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,223 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units will vested on May 3, 2022. F2 · derivative.expiration_date: 100% of the restricted stock units will vested on May 3, 2022. Read SEC document |
| May 03, 2022 Filed May 4, 2022 00:11 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Tax withholdingCommon Stock | 349 | $60.33 | $21,055.17 |
DisclosureSEC source: 0001127602-22-013124 · form4.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,528 Read SEC document |
| May 03, 2022 Filed May 4, 2022 00:11 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 2,223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-013124 · form4.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 21:22 UTC | WHIRLPOOL CORP /DE/ WHR · Entity 4355 | Tax withholdingCommon Stock | 128 | $0.00 | $0.00 |
DisclosureSEC source: 0000106640-22-000078 · wf-form4_165057613589845.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,994 Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 21:22 UTC | WHIRLPOOL CORP /DE/ WHR · Entity 4355 | GrantCommon Stock | 849 | $0.00 | $0.00 |
DisclosureSEC source: 0000106640-22-000078 · wf-form4_165057613589845.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,122 F1 · kind: Annual stock award granted under the Omnibus Stock and Incentive Plan. F1 · price: Annual stock award granted under the Omnibus Stock and Incentive Plan. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:01 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 14,665 | $0.00 Strike: $67.45 | $0.00 |
DisclosureSEC source: 0001127602-21-016788 · form4.xml · derivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,665 Underlying: Common Stock · 14,665 shares Expires 2031-05-12 F3 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:01 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Unit · Derivative | 2,223 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-016788 · form4.xml · derivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,223 Underlying: Common Stock · 2,223 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units will vest on the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting. F2 · derivative.expiration_date: 100% of the restricted stock units will vest on the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 06, 2021 Filed May 7, 2021 22:50 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 1,936 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-015950 · form4.xml · derivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,936 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units will vested on May 6, 2021. F2 · derivative.expiration_date: 100% of the restricted stock units will vested on May 6, 2021. Read SEC document |
| May 06, 2021 Filed May 7, 2021 22:50 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 1,936 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-015950 · form4.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,654 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 21:41 UTC | WHIRLPOOL CORP /DE/ WHR · Entity 4355 | Tax withholdingCommon Stock | 96 | $0.00 | $0.00 |
DisclosureSEC source: 0000106640-21-000088 · wf-form4_161912765680004.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,273 Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 21:41 UTC | WHIRLPOOL CORP /DE/ WHR · Entity 4355 | GrantCommon Stock | 634 | $0.00 | $0.00 |
DisclosureSEC source: 0000106640-21-000088 · wf-form4_161912765680004.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,369 F1 · kind: Annual stock award granted under the Omnibus Stock and Incentive Plan. F1 · price: Annual stock award granted under the Omnibus Stock and Incentive Plan. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 20:30 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Exercise / conversionDeferred Stock Unit · Derivative | 4,134.6854 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-21-000028 · edgardoc.xml · derivative · entry 3 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,578.6065 Underlying: Common Stock · 4,134.6854 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F3 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. F3 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 20:30 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Tax withholdingCommon Stock | 620 | $140.33 | $87,004.60 |
DisclosureSEC source: 0001205233-21-000028 · edgardoc.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Joint Account Disclosed balance after: 16,178 F1 · ownership.nature: Securities held by Harish and Radha Manwani. Read SEC document |
| April 05, 2021 Filed Apr 6, 2021 20:30 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | Exercise / conversionCommon Stock | 4,134 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-21-000028 · edgardoc.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Joint Account Disclosed balance after: 16,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Securities held by Harish and Radha Manwani. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 18:46 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 84.982 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-022435 · doc4.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,940.061 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 23:20 UTC | QUALCOMM INC/DE QCOM · Entity 2852 | GrantDeferred Stock Unit · Derivative | 1,922 | $0.00 | $0.00 |
DisclosureSEC source: 0001205233-21-000011 · edgardoc.xml · derivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,653.3815 Underlying: Common Stock · 1,922 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. F2 · derivative.expiration_date: Deferred Stock Units are 100% vested on the grant date. The units will be settled in shares of the Company's common stock (and partially in cash if election is made within 60 days of the date of grant) in accordance with the grant agreement on the earlier of (1) third anniversary of the date of grant, (2) death, (3) disability, or (4) a change in control. Read SEC document |
| December 03, 2020 Filed Dec 7, 2020 19:38 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 127.819 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-062031 · doc4.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,855.079 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 18:02 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 142.906 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049770 · doc4.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,727.26 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| June 18, 2020 Filed Jun 22, 2020 16:26 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 144.886 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-038184 · doc4.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,584.354 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units. Read SEC document |
| May 06, 2020 Filed May 8, 2020 00:36 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 7,886 | $0.00 Strike: $77.47 | $0.00 |
DisclosureSEC source: 0001127602-20-015849 · form4.xml · derivative · entry 5 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,886 Underlying: Common Stock · 7,886 shares Expires 2030-05-06 F4 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary from May 6, 2020 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 6, 2021 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 06, 2020 Filed May 8, 2020 00:36 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | GrantRestricted Stock Unit · Derivative | 1,936 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-015849 · form4.xml · derivative · entry 4 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,936 Underlying: Common Stock · 1,936 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F3 · derivative.exercise_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2021 or the day immediately preceding the next regular annual stockholders meeting. F3 · derivative.expiration_date: 100% of the restricted stock units will vest upon the earlier of May 6, 2021 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| May 05, 2020 Filed May 8, 2020 00:36 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionRestricted Stock Unit · Derivative | 2,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-015849 · form4.xml · derivative · entry 3 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,270 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: 100% of the restricted stock units will vested on May 5, 2020. F2 · derivative.expiration_date: 100% of the restricted stock units will vested on May 5, 2020. Read SEC document |
| May 05, 2020 Filed May 8, 2020 00:36 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Tax withholdingCommon Stock | 419 | $79.14 | $33,159.66 |
DisclosureSEC source: 0001127602-20-015849 · form4.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,718 Read SEC document |
| May 05, 2020 Filed May 8, 2020 00:36 UTC | GILEAD SCIENCES, INC. GILD · Entity 405 | Exercise / conversionCommon Stock | 2,270 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-015849 · form4.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| May 01, 2020 Filed May 5, 2020 18:53 UTC | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 9,742.12 | $13.96 | $136,000.00 |
DisclosureSEC source: 0001209191-20-027291 · doc4.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,720.268 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of May 1, 2020. The deferred stock units each represent one share of Nielsen common stock and vest in four substantially equal installments on each of August 1, 2020, November 1, 2020, February 1, 2021 and May 1, 2021, except that each of Nielsen's independent directors has agreed to reduce his or her total annual director compensation by 30% for the second and third quarters of 2020. Therefore, the amounts vesting in August and November 2020 have been reduced by 30%, and the total amount of deferred stock units reported as issued in Table I reflects such reduction. Read SEC document |
| May 01, 2020 Filed May 8, 2020 21:47 UTC Amendment | Nielsen Holdings plc NLSN · Entity 16431 | GrantCommon Stock | 11,461.32 | $13.96 | $160,000.03 |
DisclosureSEC source: 0001209191-20-028127 · doc4a.xml · nonDerivative · entry 1 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,439.468 F1 · shares: Represents deferred stock units issued to the Reporting Person at the closing trading price as of May 1, 2020. The deferred stock units each represent one share of Nielsen common stock and vest in four substantially equal installments on each of August 1, 2020, November 1, 2020, February 1, 2021 and May 1, 2021. Read SEC document |
| April 21, 2020 Filed Apr 23, 2020 21:31 UTC | WHIRLPOOL CORP /DE/ WHR · Entity 4355 | Tax withholdingCommon Stock | 222 | $98.18 | $21,795.96 |
DisclosureSEC source: 0000106640-20-000118 · wf-form4_158767748155210.xml · nonDerivative · entry 2 MANWANI HARISH · CIK 0001527726 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,735 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.